Comprehensive genomic profiling to identify recurrent kinase fusions in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Singhi, Aatur D.
Greenbowe, Joel R.
Chung, Jon
Hendifar, Andrew Eugene
Bahary, Nathan
Schrock, Alexa Betzig
Miller, Vincent A.
Stephens, Philip J.
Ross, Jeffrey S.
Ali, Siraj Mahamed
Ben George
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Univ Pittsburgh, Med Ctr, Canc Ctr Pavil, Pittsburgh, PA USA
[5] Albany Med Coll, Albany, NY 12208 USA
[6] Froedtert Med Coll Wisconsin, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
292
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
  • [32] Oncogenic roles of CEACAM6 in pancreatic ductal adenocarcinoma.
    Mahadevan, Daruka
    Pandey, Ritu
    Chen, Yuliang
    Essif, Jacob
    Al-Khinji, Aisha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
    Singh, Ritu R.
    Goldberg, Johanna
    Varghese, Anna M.
    Yu, Kenneth H.
    Park, Wungki
    O'Reilly, Eileen M.
    CANCER TREATMENT REVIEWS, 2019, 75 : 27 - 38
  • [34] NAMPT expression in stage I/II pancreatic ductal adenocarcinoma.
    Davis, Katelynn
    Dunseth, Craig
    Mott, Sarah L.
    Bellizzi, Andrew
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Comprehensive genomic profiling (CGP) utilizing cell-free DNA (cfDNA) in patients (pts) with pancreatic ductal adenocarcinoma (PDAC).
    George, Ben
    Haberberger, James
    Ferguson, Naomi L.
    Gjoerup, Ole
    McGregor, Kimberly
    Hendifar, Andrew Eugene
    Laheru, Daniel A.
    Weekes, Colin D.
    Ross, Jeffrey S.
    Hemmerich, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [36] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [37] The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma.
    Hummel, Lauren
    Xie, Irene
    Ng, Karen
    Zhang, Amy
    Ramotar, Stephanie
    Dodd, Anna
    O'Kane, Grainne
    Knox, Jennifer
    Wilson, Julie
    Gallinger, Steven
    Notta, Faiyaz
    CANCER RESEARCH, 2022, 82 (22) : 81 - 81
  • [38] Prognostic influence of waiting time in management of pancreatic ductal adenocarcinoma.
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Ohira, Hiromasa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Targeting importin-YAP axis in pancreatic ductal adenocarcinoma.
    Zeng, Renya
    Dong, Jixin
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma.
    Sharma, Padmanee
    Dirix, Luc
    De Vos, Filip Yves Francine Leon
    Allison, James Patrick
    Decoster, Lore
    Zaucha, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345